Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kidney & blood pressure research·2018
Same author

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Clinical and experimental nephrology·2017
Same author

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Clinical kidney journal·2016
Same author

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

BMC nephrology·2016
Same author

Bariatric surgery and the kidney-much benefit, but also potential harm.

Clinical kidney journal·2016
Same author

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Journal of hypertension·2016

Related Experiment Video

Updated: May 13, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Vascular calcification--is aldosterone a culprit?

Florian Lang1, Eberhard Ritz, Jakob Voelkl

  • 1Department of Physiology, University of Tübingen, Tübingen, Germany. florian.lang@uni-tuebingen.de

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|March 12, 2013
PubMed
Summary

High phosphate levels and aldosterone contribute to vascular calcification in chronic kidney disease (CKD). Spironolactone, a mineralocorticoid receptor antagonist, reversed these detrimental osteoinductive processes in mice and human cells.

Keywords:
chronic kidney diseaseklothomineralocorticoid receptorosteoinductive signallingspironolactone

More Related Videos

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Related Experiment Videos

Last Updated: May 13, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Chronic kidney disease (CKD) is linked to vascular calcification, increasing mortality.
  • Klotho-hypomorphic (kl/kl) mice exhibit vascular calcification, hyperphosphataemia, and hyperaldosteronism, mirroring CKD complications.
  • Mineralocorticoids play a role in vascular osteoinductive signaling, exacerbating calcification.

Purpose of the Study:

  • To investigate the role of aldosterone in promoting vascular calcification in kl/kl mice and human aortic vascular smooth muscle cells (HAoSMCs).
  • To evaluate the therapeutic potential of spironolactone in reversing aldosterone-induced vascular calcification.

Main Methods:

  • Treatment of kl/kl mice and HAoSMCs with aldosterone and spironolactone.
  • Analysis of gene and protein expression related to osteogenic pathways (Pit1, Tnfα, Msx2, Cbfa1/Runx2, Osterix, Alp).
  • Silencing of the phosphate transporter Pit1 in HAoSMCs.

Main Results:

  • Spironolactone treatment reduced vascular osteoinductive processes and reversed osteogenic gene expression in kl/kl mice.
  • Aldosterone alone induced an osteogenic program in HAoSMCs, potentiated by phosphate.
  • Spironolactone and Pit1 silencing reversed aldosterone-induced osteogenic signaling in HAoSMCs.

Conclusions:

  • Vascular calcification in CKD is driven by both high phosphate and aldosterone-mediated osteoinductive signaling.
  • Spironolactone demonstrates potential in mitigating aldosterone's contribution to vascular calcification.
  • Further clinical studies are needed to confirm aldosterone's role and spironolactone's efficacy in CKD patients.